From defining the future of medical technology to researching cures for diseases and changing the way health insurance is delivered, the healthcare companies listed on the New York Stock Exchange are shaping the future of their industry.
Five years after spinning off its pharma business, the health solutions giant is focused on the future.
Q&A with Press Ganey CEO Patrick T. Ryan
Evolent Health is prescribing transformation
First Trust's Ryan Issakainen discusses the future of the industry
Diplomat Pharmacy's CEO Phil Hagerman and the healing of a community